Inventor · disambiguated record
Neil John Press
Also filed as: PRESS NEIL J · PRESS NEIL JOHN
14 granted patents·9 pending applications·124 citations·filing 2001–2014
92Inventor score
Technology areasA61P
Top patents by PatentIndex Score
23 records- 0190US8722925B2Squaramide derivatives as CXCR2 antagonistBAETTIG URS·Filed 2012·Granted May 13, 2014·13 cites·7 claims
- 0290US7989497B2Squaramide derivatives as CXCR2 antagonistNOVARTIS AG·Filed 2009·Granted Aug 2, 2011·13 cites·16 claims
- 0389US9115087B2Squaramide derivatives as CXCR2 antagonistBAETTIG URS·Filed 2014·Granted Aug 25, 2015·11 cites·13 claims
- 0489US8288588B2Squaramide derivatives as CXCR2 antagonistBAETTIG URS·Filed 2011·Granted Oct 16, 2012·11 cites·15 claims
- 0588US8329754B2Squaramide derivatives as CXCR2 antagonistBAETTIG URS·Filed 2011·Granted Dec 11, 2012·11 cites·9 claims
- 0687US8153669B2Quaternary ammonium salts as M3 antagonistsPRESS NEIL JOHN·Filed 2005·Granted Apr 10, 2012·16 cites·8 claims
- 0781US8383625B2Pyrrolidinium derivatives as M3 muscarnic receptor antagonistsNOVARTIS AG·Filed 2005·Granted Feb 26, 2013·14 cites·9 claims
- 0878US7723356B2Quinuclidine derivatives and their use as muscarinic m3 receptor antagonistsNOVARTIS AG·Filed 2005·Granted May 25, 2010·3 cites·8 claims
- 0975US7273875B2Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (PDE4) inhibitorsNOVARTIS AG·Filed 2002·Granted Sep 25, 2007·10 cites·14 claims
- 1075US7109202B2Aminothaizoles and their use as adenosine receptor antagonistsNOVARTIS AG·Filed 2001·Granted Sep 19, 2006·8 cites·11 claims
- 1172US7745462B2Quinoline-2-one derivatives for the treatment of airways diseasesNOVARTIS AG·Filed 2004·Granted Jun 29, 2010·7 cites·12 claims
- 1270US7468370B2[1,7]naphthyridines as PDE4 inhibitorsNOVARTIS AG·Filed 2003·Granted Dec 23, 2008·6 cites·10 claims
- 1369US8183281B2CXC-chemokine receptor ligandsPRESS NEIL JOHN·Filed 2008·Granted May 22, 2012·1 cites·6 claims
- 1450US2011009429A1Heterocyclic compounds as inhibitors of cxcr2OAKLEY PAUL·Filed 2009·Application pending·0 cites
- 1546US2009023769A1Organic CompoundsNOVARTIS AG·Filed 2007·Application pending·0 cites
- 1645US2009264459A1Organic CompoundsCOLLINGWOOD STEPHEN PAUL·Filed 2007·Application pending·0 cites
- 1745US2010069407A1CXCR2 inhibitorsPRESS NEIL JOHN·Filed 2007·Application pending·0 cites
- 1842US2007225335A1Pyrazole Derivatives for Treating Condit Ions Mediated by Activation of the Adeno Sine A2B or A3 ReceptorBLOOMFIELD GRAHAM C·Filed 2005·Application pending·0 cites
- 1942US2010063080A1CXCR2 inhibitorsPRESS NEIL JOHN·Filed 2007·Application pending·0 cites
- 2042US2008306064A1Benzimidazole DerivativesBROWN LYNDON NIGEL·Filed 2006·Application pending·0 cites
- 2140US8084463B2Quinuclidine derivatives and their use as muscarinic M3 receptor antagonistsPRESS NEIL J·Filed 2010·Granted Dec 27, 2011·0 cites·7 claims
- 2239US2009233938A1Thiazole derivatives as a2b antagonistsPRESS NEIL JOHN·Filed 2005·Application pending·0 cites
- 2334US2009298824A1Organic compoundsPRESS NEIL J·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Neil John Press files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →